Literature DB >> 12763931

IL-15 drives neonatal T cells to acquire CD56 and become activated effector cells.

Sharon Cookson1, Denis Reen.   

Abstract

Expression of one or more natural killer (NK) receptors on T cells may correlate with effector function. This study investigated the frequency of neonatal NK receptor-positive (NKR+) T cells and their expansionary properties with interleukin-2 (IL-2), IL-7, or IL-15. While cord blood contains significantly decreased frequencies of NKR+ T cells compared with adult blood, newborn CD56+CD3+ cells could be expanded 200-fold during culture with IL-15. By depleting CD56+ cells, we were able to determine that this expansion was due to a subpopulation of T cells acquiring CD56 expression. Moreover, CD56 acquisition was associated with a distinct CD8+CD25+ interferon gamma-positive (IFN-gamma+) phenotype. This property could therefore be exploited during bone marrow reconstitution and may partially account for the resilience of the newborn to infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12763931     DOI: 10.1182/blood-2003-01-0232

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

Authors:  Thomas A Stoklasek; Kimberly S Schluns; Leo Lefrançois
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

2.  Interleukin-15 enhances T-cell responses by stimulation with dendritic cells.

Authors:  Yu Zhao; Ke Cheng; Yang Wu; Xing-Chen Peng; Ye Chen; Ben-Xu Tan; Jun Ge; Hang Dong; Meng Wei; Feng Gao; Jing-Mei Su; Jian-Mei Hou; Ji-Yan Liu
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

3.  Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.

Authors:  Qin Tang; Bartosz Grzywacz; Hongbo Wang; Nandini Kataria; Qing Cao; John E Wagner; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 4.  T cell-mediated immune responses in human newborns: ready to learn?

Authors:  A Marchant; M Goldman
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood transplants.

Authors:  Archana Thakur; Carly Sorenson; Oxana Norkina; Dana Schalk; Voravit Ratanatharathorn; Lawrence G Lum
Journal:  Transfusion       Date:  2011-07-11       Impact factor: 3.157

6.  Prolonged exposure of naïve CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length.

Authors:  Diana L Wallace; Marion Bérard; Maria V D Soares; Janine Oldham; Joanne E Cook; Arne N Akbar; David F Tough; Peter C L Beverley
Journal:  Immunology       Date:  2006-10       Impact factor: 7.397

7.  Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

Authors:  Patrick J Hanley; Conrad Russell Young Cruz; Barbara Savoldo; Ann M Leen; Maja Stanojevic; Mariam Khalil; William Decker; Jeffrey J Molldrem; Hao Liu; Adrian P Gee; Cliona M Rooney; Helen E Heslop; Gianpietro Dotti; Malcolm K Brenner; Elizabeth J Shpall; Catherine M Bollard
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

8.  Killer cell immunoglobulin-like receptor expression induction on neonatal CD8(+) T cells in vitro and following congenital infection with Trypanosoma cruzi.

Authors:  Emmanuel Hermann; Aurélie Berthe; Carine Truyens; Cristina Alonso-Vega; Rudy Parrado; Faustino Torrico; Yves Carlier; Véronique M Braud
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

9.  Human cord blood γδ T cells expressing public Vγ2 chains dominate the response to bisphosphonate plus interleukin-15.

Authors:  Cristiana Cairo; Bertrand Sagnia; Giulia Cappelli; Vittorio Colizzi; Rose G F Leke; Robert J Leke; C David Pauza
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

10.  Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.

Authors:  Sébastien Anguille; Eva Lion; Jurjen Tel; I Jolanda M de Vries; Karen Couderé; Phillip D Fromm; Viggo F Van Tendeloo; Evelien L Smits; Zwi N Berneman
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.